bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. [electronic resource]
Producer: 20030512Description: 329-34 p. digitalISSN:- 1541-2016
- Adenocarcinoma -- diagnosis
- Biomarkers -- analysis
- Combined Modality Therapy
- Humans
- Immunohistochemistry
- Prognosis
- Proto-Oncogene Proteins -- analysis
- Proto-Oncogene Proteins c-bcl-2 -- analysis
- Radiotherapy, Adjuvant -- standards
- Rectal Neoplasms -- diagnosis
- Treatment Failure
- bcl-2-Associated X Protein
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.